TG and ischemic stroke: An elevated FT4/FT3 ratio may serve as a novel biomarker for predicting poor outcomes in ischemic stroke, reflecting thyroid hormone metabolic dysfunction that potentially exacerbates inflammation and impairs neuronal repair.